CIM Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$345K Sell
5,495
-23
-0.4% -$1.6K 0.09% 180
2025
Q4
$366K Hold
5,518
0.1% 164
2025
Q3
$371K Sell
5,518
-5,645
-51% -$447K 0.1% 160
2025
Q2
$921K Buy
11,163
+5,573
+100% +$437K 0.18% 107
2025
Q1
$382K Sell
5,590
-5
-0.1% -$408 0.09% 141
2024
Q4
$435K Sell
5,595
-81
-1% -$6K 0.13% 134
2024
Q3
$381K Sell
5,676
-230
-4% -$18.9K 0.11% 151
2024
Q2
$670K Sell
5,906
-75
-1% -$9.48K 0.21% 96
2024
Q1
$830K Hold
5,981
0.25% 78
2023
Q4
$742K Hold
5,981
0.24% 84
2023
Q3
$558K Sell
5,981
-119
-2% -$13.4K 0.2% 105
2023
Q2
$784K Buy
6,100
+12
+0.2% +$1.45K 0.27% 80
2023
Q1
$707K Buy
6,088
+656
+12% +$73.4K 0.26% 85
2022
Q4
$615K Sell
5,432
-136
-2% -$14.9K 0.24% 89
2022
Q3
$448K Hold
5,568
0.2% 110
2022
Q2
$415K Buy
+5,568
New +$508K 0.17% 125
2021
Q3
Sell
-14,648
Closed -$1.56M 309
2021
Q2
$1.56M Buy
14,648
+5,780
+65% +$555K 0.48% 26
2021
Q1
$797K Sell
8,868
-300
-3% -$28.2K 0.25% 72
2020
Q4
$847K Buy
+9,168
New +$819K 0.28% 66
2015
Q2
Sell
-15,472
Closed -$241K 263
2015
Q1
$241K Buy
+15,472
New +$234K 0.1% 202

Other funds holding DXCM

CIM Investment Management's DXCM Position: Q1 2026 in Review

CIM Investment Management reduced its DexCom (DXCM) stake by 0.42% in Q1 2026, selling an estimated $1.6K and leaving 5,495 shares worth $345K. The position accounts for 0.09% of the portfolio, ranked #180.

CIM Investment Management first reported a position in DXCM in Q1 2015 and has held it in 20 quarters since. The position peaked at $1.56M in Q2 2021. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • CIM Investment Management held 5,495 shares of DexCom worth $345K as of Q1 2026.
  • CIM Investment Management sold 23 DexCom shares in Q1 2026, an estimated $1.6K.
  • DexCom made up 0.09% of CIM Investment Management's portfolio in Q1 2026, its #180 holding.
  • CIM Investment Management first reported a position in DexCom in Q1 2015 and has held it in 20 quarters since.
  • CIM Investment Management's DexCom position peaked at $1.56M in Q2 2021.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on CIM Investment Management's 13F filing for Q1 2026, filed 19 May 2026.